Delivery Order SPE2DE23D0008-SPE2D626F41FK
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order for Natrelle Inspira SSL 290CC breast implants by the Defense Logistics Agency's Medical Supply Chain division on January 14, 2026. The contract, classified as a child delivery order under a larger Indefinite Delivery vehicle, carries an ultimate completion date of January 16, 2026 and was awarded without a set-aside designation, reflecting Allergan's position as a sole-source provider of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on January 22, 2026, for Natrelle Inspira SSM 520cc breast implants. The contract, which carries an ultimate completion date of January 26, 2026, represents a child order issued against one of Allergan's larger Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical. This award was made without a set-aside...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 delivery order on February 3, 2026, for Natrelle Inspira SSF 520CC breast implants. This fixed-price contract with economic price adjustment will be performed in Irvine, California, with a completion date of February 5, 2026. The award was issued without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized breast implant systems to the federal government. The contract is funded...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,400 for Natrelle Inspira SSLP 320cc breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment will be performed at the company's facility in Irvine, California, with an ultimate completion date of February 6, 2026. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order on November 18, 2025, for Natrelle Inspira SSM 255CC breast implants. This delivery order, issued without set-aside designation, is scheduled for completion by December 3, 2025, and represents a child contract under one of Allergan's two significant Indefinite Delivery/Indefinite Quantity contracts with the Defense Logistics Agency Troop Support Medical. The $13.5 million IDV for Natrelle breast...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order for Natrelle Inspira SSM 275CC breast implants by the Defense Logistics Agency's Medical Supply Chain division on December 18, 2025. This delivery order, which is a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements, carries an ultimate completion date of January 7, 2026, and will be fulfilled at the contractor's facility in Irvine, California. The contract...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order for Natrelle Inspira SSX 525cc breast implants by the Defense Logistics Agency's Medical Supply Chain division on February 3, 2026, with an ultimate completion date of February 5, 2026. This delivery order is issued without set-aside designation and will be performed in Irvine, California. The award represents a task order issued under one of Allergan's larger Indefinite Delivery Vehicle contracts...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on November 26, 2025, with completion scheduled for December 1, 2025. The contract covers the delivery of Natrelle Inspira SCM 485CC breast implants to support surgical procedures at military treatment facilities and related federal healthcare systems. This delivery order was issued without a set-aside designation, reflecting...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 delivery order by the Defense Logistics Agency's Medical Supply Chain division for Natrelle Inspira SSF 450cc breast implants. This fixed-price contract with economic price adjustment was executed on February 3, 2026, with an ultimate completion date of February 6, 2026, and carries no set-aside designation. The product will be delivered to Irvine, California, reflecting Allergan's established role as a sole-source supplier...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F41FKDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on February 3, 2026, for Natrelle Inspira SSF 265cc breast implants with an ultimate completion date of February 5, 2026. The contract is funded through the Medical Supply Chain division of the Defense Logistics Agency and will be performed in Irvine, California. This award was not designated as a set-aside contract, reflecting Allergan's position as a sole-source provider of specialized breast implant systems to the Department of Defense. This delivery order is issued under one of Allergan USA Inc.'s two significant Indefinite Delivery/Indefinite Quantity (IDV) contracts with the Defense Logistics Agency Troop Support Medical, specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and supports reconstructive and aesthetic surgical procedures across military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. Allergan's specialized medical device offerings and established vendor status enable the timely fulfillment of critical surgical supplies to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/2/26 |